In pharma, a BMR is a Batch Manufacturing Record. It is the complete, controlled record that shows how a specific batch of product was actually manufactured, tested, and handled, compared to the approved process.

What a BMR includes

Depending on the product and site procedures, a BMR typically contains:

  • Reference to the master manufacturing record / master batch record (MMR/MBR)
  • Material details: lot numbers, quantities, expiry/retest dates, and status
  • Executed process steps: equipment used, setpoints, actual values, and operators
  • In-process controls and test results, including any deviations and investigations
  • Environmental or line clearance checks, where applicable
  • Labeling and packaging details and line reconciliation results
  • Signatures / e-signatures and timestamps for all critical actions and reviews
  • Final quality review and batch disposition (e.g., released, rejected, quarantined)

Why the BMR matters in regulated manufacturing

The BMR is a core GMP record because it:

  • Provides documented evidence that the batch followed the approved and validated process
  • Enables traceability of materials, equipment, personnel, and process parameters
  • Supports investigations, complaints handling, and product quality reviews
  • Is a primary focus area in regulatory inspections and customer audits

A complete, legible, and accurate BMR does not guarantee a positive audit outcome, but poor BMR practices almost always create findings or concerns.

Paper vs electronic BMRs in brownfield environments

In many pharma plants, BMRs exist as a mix of paper and electronic records:

  • Paper BMRs are still common where older equipment, limited integration, or validation cost makes full electronic execution difficult. They are simple to deploy but prone to data entry errors, missing signatures, and legibility issues.
  • Electronic BMRs (eBMR) are typically implemented via MES or eDHR/EBR systems. They can enforce sequence, checks, and calculations, but require validated integrations, robust change control, and careful management of hybrid workflows.

In brownfield environments with legacy MES/ERP/PLM/QMS stacks, full replacement of existing batch documentation processes is rare. Incremental approaches are more common, for example:

  • Digitizing specific high-risk or high-volume steps while keeping the rest on paper
  • Capturing critical data electronically at the equipment level and attaching printouts to a paper BMR
  • Running hybrid BMRs where some sections are executed in MES and others via controlled paper forms, with clear linking and reconciliation rules

Attempts to fully replace legacy BMR processes and systems often stall due to validation burden, downtime risk for critical lines, integration complexity with older equipment, and the need to maintain historical traceability across long product lifecycles.

Key constraints and good practices

The exact structure and management of BMRs vary by site, but some common constraints and practices are:

  • Change control: Any change to BMR format, content, or execution flow should go through formal change control with impact assessment and, where needed, re-validation.
  • Document control: Only the current approved version of the batch record template (the master) should be used to generate BMRs. Obsolete versions must be clearly segregated.
  • Traceability: BMRs must be linkable to equipment logs, calibration records, analytical results, deviations, CAPAs, and supply chain data. In fragmented system landscapes this often depends on robust identifiers and disciplined data entry.
  • Data integrity: ALCOA+ principles apply. Corrections, overrides, and rework should be clearly documented and attributable.
  • Retention: BMRs typically must be retained for many years; storing and retrieving both paper and electronic records reliably over long horizons is a nontrivial design and cost consideration.

Because of these factors, any change to how BMRs are created, captured, or stored should be planned with cross-functional input from manufacturing, quality, IT, and validation, with explicit acknowledgment of brownfield constraints and long equipment lifecycles.

Related Blog Articles

Get Started

Built for Speed, Trusted by Experts

Whether you're managing 1 site or 100, Connect 981 adapts to your environment and scales with your needs—without the complexity of traditional systems.

Get Started

Built for Speed, Trusted by Experts

Whether you're managing 1 site or 100, C-981 adapts to your environment and scales with your needs—without the complexity of traditional systems.

{ "@context": "https://schema.org", "@type": "BreadcrumbList", "@id": "https://connect981.com/faqs/what-is-a-bmr-in-pharma#breadcrumb", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Connect 981", "item": "https://connect981.com/" }, { "@type": "ListItem", "position": 2, "name": "FAQs", "item": "https://connect981.com/faqs/" }, { "@type": "ListItem", "position": 3, "name": "What is a BMR in pharma?", "item": "https://connect981.com/faqs/what-is-a-bmr-in-pharma" } ] }